Tobacco and COPD: presenting the World Health Organization (WHO) Tobacco Knowledge Summary.

Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101090633 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-993X (Electronic) Linking ISSN: 14659921 NLM ISO Abbreviation: Respir Res Subsets: MEDLINE

Publication: 2001- : London : BioMed Central Ltd.
Original Publication: London : Current Science Ltd., c2000-

Pulmonary Disease, Chronic Obstructive*/epidemiology ; Pulmonary Disease, Chronic Obstructive*/prevention & control ; World Health Organization*; Humans ; Smoking Cessation ; Health Knowledge, Attitudes, Practice ; Smoking/adverse effects ; Smoking/epidemiology

The WHO recently published a Tobacco Knowledge Summary (TKS) synthesizing current evidence on tobacco and COPD, aiming to raise awareness among a broad audience of health care professionals. Furthermore, it can be used as an advocacy tool in the fight for tobacco control and prevention of tobacco-related disease. This article builds on the evidence presented in the TKS, with a greater level of detail intended for a lung-specialist audience. Pulmonologists have a vital role to play in advocating for the health of their patients and the wider population by sharing five key messages: (1) Smoking is the leading cause of COPD in high-income countries, contributing to approximately 70% of cases. Quitting tobacco is an essential step toward better lung health. (2) People with COPD face a significantly higher risk of developing lung cancer. Smoking cessation is a powerful measure to reduce cancer risk. (3) Cardiovascular disease, lung cancer and type-2 diabetes are common comorbidities in people with COPD. Quitting smoking not only improves COPD management, but also reduces the risk of developing these coexisting conditions. (4) Tobacco smoke also significantly impacts children's lung growth and development, increasing the risk of respiratory infections, asthma and up to ten other conditions, and COPD later in life. Governments should implement effective tobacco control measures to protect vulnerable populations. (5) The tobacco industry's aggressive strategies in the marketing of nicotine delivery systems and all tobacco products specifically target children, adolescents, and young adults. Protecting our youth from these harmful tactics is a top priority.
(© 2024. The Author(s).)

Am J Respir Crit Care Med. 2020 Mar 15;201(6):735-739. (PMID: 31751151)
Lancet. 2007 Sep 1;370(9589):751-7. (PMID: 17765524)
Exp Toxicol Pathol. 2005 Jul;57 Suppl 1:43-73. (PMID: 16092717)
Int J Environ Res Public Health. 2021 Apr 13;18(8):. (PMID: 33924379)
Lancet. 2007 Sep 1;370(9589):765-73. (PMID: 17765526)
Eur J Gastroenterol Hepatol. 2000 Aug;12(8):837-42. (PMID: 10958210)
Int J Cardiol. 2008 Apr 10;125(2):209-15. (PMID: 18221802)
Annu Rev Physiol. 2022 Feb 10;84:611-629. (PMID: 34724436)
Clin Med (Lond). 2006 Mar-Apr;6(2):190-6. (PMID: 16688981)
Eur Respir J. 2015 May;45(5):1258-72. (PMID: 25745049)
Drugs. 2018 Nov;78(16):1717-1740. (PMID: 30392114)
Tob Control. 2018 Nov;27(Suppl 1):s9-s12. (PMID: 30131374)
Tob Control. 2010 Oct;19(5):349-50. (PMID: 20876073)
Am J Respir Crit Care Med. 2007 Apr 1;175(7):712-9. (PMID: 17185647)
Nat Genet. 2019 Mar;51(3):481-493. (PMID: 30804560)
Sci Rep. 2017 Oct 17;7(1):13392. (PMID: 29042607)
J Clin Med. 2022 Dec 16;11(24):. (PMID: 36556082)
Tuberk Toraks. 2016 Mar;64(1):94-6. (PMID: 27266294)
Eur Respir J. 2009 May;33(5):1165-85. (PMID: 19407051)
Annu Rev Pathol. 2009;4:435-59. (PMID: 18954287)
Eur Respir J. 2019 Jan 24;53(1):. (PMID: 30545980)
Tob Control. 2018 Nov;27(Suppl 1):s26-s29. (PMID: 30185530)
Lancet Respir Med. 2014 Oct;2(10):823-60. (PMID: 25193349)
Nat Commun. 2019 Dec 6;10(1):5587. (PMID: 31811131)
Am J Public Health. 2007 Nov;97(11):1981-91. (PMID: 17666709)
Nat Rev Dis Primers. 2015 Dec 03;1:15076. (PMID: 27189863)
Transl Lung Cancer Res. 2021 Mar;10(3):1266-1276. (PMID: 33889508)
Chest. 2005 Apr;127(4):1205-11. (PMID: 15821196)
Korean J Intern Med. 2019 Nov;34(6):1272-1278. (PMID: 31610634)
Lancet Respir Med. 2022 May;10(5):447-458. (PMID: 35279265)
Respir Care. 2013 May;58(5):858-66. (PMID: 22906542)
Am J Respir Crit Care Med. 2011 Oct 15;184(8):913-9. (PMID: 21799072)
Int J Chron Obstruct Pulmon Dis. 2016 Mar 29;11:637-48. (PMID: 27099481)
Chest. 2009 Dec;136(6):1480-1488. (PMID: 19617404)
Eur Respir J. 2008 Nov;32(5):1371-85. (PMID: 18978137)
Lancet. 2005 Jun 25-Jul 1;365(9478):2225-36. (PMID: 15978931)
Lancet Respir Med. 2023 Nov;11(11):1020-1034. (PMID: 37696283)
Int J Chron Obstruct Pulmon Dis. 2014 May 27;9:533-42. (PMID: 24920891)
Tob Control. 2022 Mar;31(2):129-137. (PMID: 35241576)
Am J Respir Crit Care Med. 2007 Aug 1;176(3):243-52. (PMID: 17431226)
Sci Rep. 2023 Dec 8;13(1):21781. (PMID: 38065965)
Clin Sci (Lond). 2019 Jul 25;133(14):1663-1703. (PMID: 31346069)
BMC Pulm Med. 2022 Jul 17;22(1):275. (PMID: 35843928)
Eur Respir J. 2024 Feb 22;63(2):. (PMID: 38316440)
Int J Mol Sci. 2023 Mar 29;24(7):. (PMID: 37047427)
Chest. 2014 Oct;146(4):924-931. (PMID: 24557573)
Semin Respir Crit Care Med. 2015 Aug;36(4):491-507. (PMID: 26238637)
N Engl J Med. 2011 Oct 27;365(17):1567-75. (PMID: 22029978)
Respir Med. 2006 Jun;100(6):1110-6. (PMID: 16236491)
Indoor Air. 2005 Apr;15(2):135-40. (PMID: 15737156)
Recent Pat Anticancer Drug Discov. 2019;14(1):39-52. (PMID: 30605063)
Pulmonology. 2019 May - Jun;25(3):168-176. (PMID: 30527374)
Am J Prev Med. 2020 Mar;58(3):336-342. (PMID: 31902685)
Front Immunol. 2020 Sep 02;11:1957. (PMID: 32983127)
Thorax. 2013 May;68(5):410-20. (PMID: 23299965)
PLoS One. 2018 Jul 25;13(7):e0198681. (PMID: 30044773)
N Engl J Med. 1962 Oct 18;267:787-94. (PMID: 14012834)
Eur Respir J. 2002 Apr;19(4):632-8. (PMID: 11998991)
Thorax. 2016 Mar 9;71:411-420. (PMID: 26962015)
Pulm Circ. 2013 Jan;3(1):160-4. (PMID: 23662194)
Environ Res. 2021 Jun;197:111116. (PMID: 33823195)
Environ Health Prev Med. 2010 Jul;15(4):236-43. (PMID: 21432551)
Int J Environ Res Public Health. 2022 Jul 19;19(14):. (PMID: 35886604)
Am J Physiol Lung Cell Mol Physiol. 2020 Oct 1;319(4):L585-L595. (PMID: 32726146)
J Am Geriatr Soc. 2009 Aug;57(8):1453-7. (PMID: 19515110)
PLoS One. 2021 Nov 18;16(11):e0260154. (PMID: 34793517)
BMJ. 2022 Jul 27;378:e069679. (PMID: 35896191)
Respir Res. 2005 May 26;6:45. (PMID: 15918902)
Clin Chest Med. 2014 Mar;35(1):17-27. (PMID: 24507834)
Tob Control. 2018 Nov;27(Suppl 1):s1-s6. (PMID: 30352841)
Int J Environ Health Res. 2020 Feb;30(1):75-88. (PMID: 30754998)
Eur Respir Rev. 2014 Sep;23(133):345-9. (PMID: 25176970)
Int J Chron Obstruct Pulmon Dis. 2016 Sep 22;11:2359-2367. (PMID: 27703346)
Lancet Respir Med. 2015 Oct;3(10):782-95. (PMID: 26404118)
Dig Dis Sci. 2008 Aug;53(8):2027-32. (PMID: 18030622)
Pediatr Pulmonol. 2020 May;55(5):1224-1236. (PMID: 32168438)
Eur Respir J. 2006 Dec;28(6):1245-57. (PMID: 17138679)
ERJ Open Res. 2022 Dec 05;8(4):. (PMID: 36478915)
Respirology. 2015 Jan;20(1):101-7. (PMID: 25297724)
Lancet. 2024 Apr 13;403(10435):1494-1503. (PMID: 38490231)
J Bone Metab. 2016 Aug;23(3):111-20. (PMID: 27622174)
Int J Environ Res Public Health. 2019 Oct 16;16(20):. (PMID: 31623202)
Int J Chron Obstruct Pulmon Dis. 2015 Sep 14;10:1935-49. (PMID: 26392769)
Eur Respir J. 2009 Jul;34(1):209-18. (PMID: 19567604)
Nat Commun. 2023 Nov 14;14(1):7349. (PMID: 37963864)
N Engl J Med. 2019 Sep 26;381(13):1248-1256. (PMID: 31553836)
BMC Pulm Med. 2022 Apr 29;22(1):169. (PMID: 35488330)
Adv Pharmacol. 2024;99:327-354. (PMID: 38467485)
Nicotine Tob Res. 2020 Jun 12;22(7):1155-1161. (PMID: 31830263)
Eur Respir J. 2019 Aug 1;54(2):. (PMID: 31073084)
Lancet. 2022 Jun 11;399(10342):2227-2242. (PMID: 35533707)
JAMA. 2001 Feb 14;285(6):785-95. (PMID: 11176917)
Am J Respir Crit Care Med. 2000 Dec;162(6):2152-8. (PMID: 11112130)
Nat Rev Cancer. 2022 Mar;22(3):143-155. (PMID: 34980891)
J Osteoporos. 2011;2011:293808. (PMID: 21876833)
ERJ Open Res. 2023 Dec 27;9(6):. (PMID: 38152085)
ERJ Open Res. 2019 Feb 11;5(1):. (PMID: 30775377)
ERJ Open Res. 2024 Feb 12;10(1):. (PMID: 38348240)
Eur Respir J. 2023 Sep 9;62(3):. (PMID: 37690786)
Am J Prev Med. 2018 Sep;55(3):345-352. (PMID: 30122215)
Thorax. 2022 Jan;77(1):94-101. (PMID: 33986144)
Respir Med. 2015 Sep;109(9):1147-54. (PMID: 26166017)
Pulm Med. 2022 Aug 21;2022:9799858. (PMID: 36046848)
Respirology. 2017 Aug;22(6):1125-1132. (PMID: 28326668)
Am J Respir Crit Care Med. 2013 Oct 15;188(8):941-7. (PMID: 23972146)
Adv Exp Med Biol. 2020;1228:355-368. (PMID: 32342470)
Eur J Radiol. 2017 Apr;89:177-181. (PMID: 28267536)
Am J Med. 2003 Jan;114(1):10-4. (PMID: 12543283)
Clin Respir J. 2020 Jan;14(1):29-34. (PMID: 31613417)
Clin Respir J. 2022 Jul;16(7):487-496. (PMID: 35688435)
Psychosomatics. 2006 Jul-Aug;47(4):312-9. (PMID: 16844889)
Respir Res. 2024 May 31;25(1):229. (PMID: 38822332)
Metallomics. 2011 Nov;3(11):1181-98. (PMID: 21799956)
Handb Exp Pharmacol. 2009;(192):61-82. (PMID: 19184646)
Arch Bronconeumol. 2021 Aug;57(8):519-520. (PMID: 34053892)
J Gen Intern Med. 2017 Dec;32(12):1315-1322. (PMID: 28884423)

001 International WHO_ World Health Organization

Keywords: Chronic obstructive pulmonary disease; Smoking; Smoking cessation; Tobacco control

Date Created: 20240911 Date Completed: 20240912 Latest Revision: 20241130

20241202

PMC11391604

10.1186/s12931-024-02961-5

39261873